CONNECT WITH US
Funding Tracker

Funding Tracker

Kapiva crosses Rs 460 Cr revenue in FY26; targets EBITDA profitability by Q4 FY27

Entrackr logo

Published on

Add as a preferred source on Google
Kapiva crosses Rs 460 Cr revenue in FY26; targets EBITDA profitability by Q4 FY27

Following 50% growth in FY25, Ayurveda wellness brand Kapiva continued its growth momentum in FY26, with its revenue crossing Rs 460 crore. The company also managed to keep its losses largely stable despite higher spending on marketing and other operating costs, while its margins improved after excluding employee stock option (ESOP) expenses.

Kapiva’s revenue from operations grew 36.5% year-on-year to Rs 464 crore in FY26 from Rs 340 crore in FY25, according to its annual financial statements sourced from the Registrar of Companies (RoC). Including non-operating income of Rs 10 crore, its total income stood at Rs 474 crore.

Founded in 2015, Kapiva offers Ayurvedic nutrition and wellness products across categories such as diabetes management, liver health, hormonal balance, energy and sports nutrition. Sales of its products remained the company’s sole source of operating revenue.

Advertising and promotional expenses remained Kapiva’s largest cost component, accounting for nearly 48% of its total expenditure. The expense increased 39.8% to Rs 260 crore in FY26 from Rs 186 crore in the previous fiscal year.

The firm’s procurement costs rose 22.6% to Rs 117 crore, while employee benefit expenses stood at Rs 78 crore. Higher spending across these and other heads, including legal, technology and freight, pushed its total expenditure up 31.2% to Rs 547 crore in FY26 from Rs 417 crore in FY25.

Despite the increase in expenses, Kapiva’s losses remained broadly stable at Rs 72 crore in FY26, compared with Rs 69 crore a year earlier. 7% in FY25. 18 to earn every rupee of operating revenue.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.